Zobrazeno 1 - 10
of 2 090
pro vyhledávání: '"GLP‐1 receptor agonists"'
Autor:
Maria Sudoł, Katarzyna Dąbek, Michał Ochwat, Martyna Piekarska, Anna Skowronek, Aleksandra Kajtel, Gabriela Mierzwa, Zofia Sudoł
Publikováno v:
Quality in Sport, Vol 35 (2024)
ABSTRACT Introduction and purpose: There is currently a pandemic of overweight and obesity, which is closely associated with non-alcoholic fatty liver disease (NAFLD). It is the most common cause of chronic liver disease [1]. The global prevale
Externí odkaz:
https://doaj.org/article/446070d715a04669b864cb949d2d041a
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Pasireotide is an effective treatment for both Cushing’s disease (CD) and acromegaly due to its ability to suppress adrenocorticotropic hormone and growth hormone, and to normalize insulin-like growth factor-1 levels, resulting in tumor shrinkage.
Externí odkaz:
https://doaj.org/article/d0422d418aff42539e160a04d72b1f97
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/55cf44fb64564c25a4d317a2a26f8f67
Autor:
Gregory J Grosicki, Nikhil V Dhurandhar, Jessica L Unick, Shawn M Arent, J Graham Thomas, Holly Lofton, Madelyn C Shepherd, Jessica Kiel, Christopher Coleman, Satya S Jonnalagadda
Publikováno v:
Current Developments in Nutrition, Vol 8, Iss 11, Pp 104486- (2024)
Obesity is a public health crisis, with prevalence rates tripling over the past 60 y. Although lifestyle modifications, such as diet and physical activity, remain the first-line treatments, recent anti-obesity medications (AOMs) have been shown to ac
Externí odkaz:
https://doaj.org/article/31856573840c43e59340695e2df19fe6
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown notable advancements in managing blood sugar control. Nevertheless, there remains a gap in real-world data regarding the variation in acute pancreatitis (AP) risk among differe
Externí odkaz:
https://doaj.org/article/47b09ce3d6ee478f939c5ee0df249984
Autor:
HamaSalih RM
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 731-740 (2024)
Raz Muhammed HamaSalih Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Slemani, Kurdistan Region, IraqCorrespondence: Raz Muhammed HamaSalih, College of Pharmacy, University of Sulaimani, Town Campus, Slemani,
Externí odkaz:
https://doaj.org/article/893c3079c1f1486788de800b5a09c269
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhiyuan Cheng, Shuang Wang, Fu‐rong Li, Cheng Jin, Chunbao Mo, Jing Zheng, Xia Li, Fengchao Liang, Jinkui Yang, Dongfeng Gu
Publikováno v:
Journal of Diabetes, Vol 16, Iss 10, Pp n/a-n/a (2024)
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), a class of injectable antidiabetic drugs, have shown significant efficacies in improving glycemic and weight control in patients with type 2 diabetes (T2D). However, the
Externí odkaz:
https://doaj.org/article/bb757573ac26405dbf27de4cef7c0d18
Autor:
Mohamed E. A. Mostafa, Tariq Alrasheed
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundType 2 diabetes mellitus (T2DM) is linked to a heightened likelihood of experiencing fractures. It is crucial to ascertain whether medications used to lower blood sugar levels can elevate the risk of fractures. We aimed to investigate and c
Externí odkaz:
https://doaj.org/article/47f21d418b0641ccab2fd0fcc4196bbf
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundThe escalating global economic burden of ischemic stroke poses a significant public health challenge amid global aging trends. The broad therapeutic efficacy of new antidiabetic drugs may offer new options in the prevention and treatment of
Externí odkaz:
https://doaj.org/article/098676a1cb96438992299aa2678a1373